Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
Here's the podcast of the Q&A portion of the excellent webinar with Dr. Pennell on Molecular Markers in Management of NSCLC.
[powerpress]
dr-pennell-molecular-markers-qa-audio-podcast
dr-pennell-molecular-markers-qa-transcript
dr-pennell-molecular-markers-qa-figures
Obviously, people may have additional questions about this topic but who weren't able to attend the live program. If you'd like to ask a question about molecular markers in lung cancer after this point, Dr. Pennell and/or one of the other GRACE faculty will be happy to try to give our best answer.
By the way, thanks again to Response Genetics for their grant to support this educational program.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…